Drug Profile
Research programme: I kappa B kinase inhibitors - Pfizer
Alternative Names: IKK2 inhibitors - Pfizer; PF-184; PHA-408Latest Information Update: 23 Feb 2012
Price :
$50
*
At a glance
- Originator Pfizer
- Class Amides; Indazoles; Piperazines; Pyridines; Pyrrolidines; Small molecules
- Mechanism of Action I-kappa B kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obstructive airway disorders
Most Recent Events
- 23 Feb 2012 No development reported - Preclinical for Obstructive airway disorders in USA (Inhalation)
- 23 Feb 2012 No development reported - Preclinical for Obstructive airway disorders in USA (IV)
- 23 Feb 2012 No development reported - Preclinical for Obstructive airway disorders in USA (PO)